Associate Scientist-Biomolecular Interactions jobs in United States
cer-icon
Apply on Employer Site
company-logo

Regeneron · 1 day ago

Associate Scientist-Biomolecular Interactions

Regeneron Pharmaceuticals is seeking a motivated Scientist to join their High Throughput Antibody Screening and Biomolecular Interaction Group. The role involves supporting Therapeutics Protein activities by characterizing protein interaction kinetics and biochemical properties using various analytical technologies.

BiopharmaBiotechnologyPharmaceutical
check
Comp. & Benefits
check
H1B Sponsor Likelynote

Responsibilities

Conducting experiments including antibody characterization, method development, and analytical support for biologics development using biochemical and biophysical methods
Troubleshooting established test methods used in development and release testing of screening reagents
Tabulating results and writing summary reports of assay development
Presenting findings at group and interdepartmental meetings
Maintaining lab supplies and equipment

Qualification

SPRBLIITCBiochemical methodsBiophysical methodsTroubleshootingData managementCommunicationIndependent work

Required

Bachelors Degree +2 years experience or
Masters Degree

Benefits

Health and wellness programs (including medical, dental, vision, life, and disability insurance)
Fitness centers
401(k) company match
Family support benefits
Equity awards
Annual bonuses
Paid time off
Paid leaves (e.g., military and parental leave)

Company

Regeneron

company-logo
Regeneron Pharmaceuticals specializes in the discovery, development, and commercialization of innovative medicines.

H1B Sponsorship

Regeneron has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (157)
2024 (128)
2023 (128)
2022 (137)
2021 (104)
2020 (122)

Funding

Current Stage
Public Company
Total Funding
$15.93M
Key Investors
U.S. Department of Health & Human Services
2024-07-11Post Ipo Equity· $2.03M
2023-10-18Post Ipo Equity· $5M
2016-08-22Post Ipo Equity· $8.9M

Leadership Team

leader-logo
Aris Baras
Senior Vice President, Regeneron Pharmaceuticals, General Manager, Regeneron Genetics Center
linkedin
leader-logo
Bari Kowal
Senior Vice President, Head Development Operations & Portfolio Management
linkedin
Company data provided by crunchbase